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Abstract
Background: Takayasu arteritis (TA) is a rare form of chronic inflammatory granulomatous arteritis of the aorta and its major
branches. Late gadolinium enhancement (LGE) with magnetic resonance imaging (MRI) has demonstrated its value for the
detection of vessel wall alterations in TA. The aim of this study was to assess LGE of the coronary artery wall in patients with
TA compared to patients with stable CAD.
Methods: We enrolled 9 patients (8 female, average age 46613 years) with proven TA. In the CAD group 9 patients
participated (8 male, average age 65610 years). Studies were performed on a commercial 3T whole-body MR imaging
system (Achieva; Philips, Best, The Netherlands) using a 3D inversion prepared navigator gated spoiled gradient-echo
sequence, which was repeated 34–45 minutes after low-dose gadolinium administration.
Results: No coronary vessel wall enhancement was observed prior to contrast in either group. Post contrast, coronary LGE
on IR scans was detected in 28 of 50 segments (56%) seen on T2-Prep scans in TA and in 25 of 57 segments (44%) in CAD
patients. LGE quantitative assessment of coronary artery vessel wall CNR post contrast revealed no significant differences
between the two groups (CNR in TA: 6.062.4 and 7.362.5 in CAD; p = 0.474).
Conclusion: Our findings suggest that LGE of the coronary artery wall seems to be common in patients with TA and similarly
pronounced as in CAD patients. The observed coronary LGE seems to be rather unspecific, and differentiation between
coronary vessel wall fibrosis and inflammation still remains unclear.
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Introduction
Takayasu arteritis (TA) is a rare chronic inflammatory disease of
the large vessels and is characterized by granulomatous arteritis of
the aorta and its major branches of unknown origin. Due to the
chronic inflammatory process local artery stenosis can occur with
its characteristic symptoms of claudication and blood pressure
differences (‘‘pulseless disease’’) [1]. According to the American
College of Rheumatology (ACR) classification criteria, diagnosis of
TA is based on physical examination, laboratory findings and
imaging studies [2].
Over the past decade, magnetic resonance imaging (MRI) has
become established as a reliable non-invasive radiation free
imaging technique for diagnosis of TA which seems to be
comparable to the standard technique of x-ray angiography [3].
Typical signs of TA in MRI are vessel wall thickening and stenotic
areas in large artery vessels. Moreover MRI provides the
possibility to depict vessel wall edema as a sign of inflammation
by T1 and T2 weighted images [4].
Coronary artery involvement may appear in 10 to 30% [5,6] of
patients with TA. Myocardial infarction can occur in about 10%,
while angina pectoris as a typical symptom seems to be rare [7],
but heart failure is common and develops in up to 60% [8],
suggesting the importance of detecting coronary involvement in
TA.
It is well known that inflammatory processes are key factors in
the development and progression of coronary artery disease (CAD)
[9,10].
Recently, cardiac magnetic resonance (CMR) showed promis-
ing results in the detection of coronary artery stenosis [11–13] and
describing coronary vessel wall alterations in patients with stable
CAD post administration of gadolinium [14–16]. It is well known
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that coronary involvement occurs in inflammatory disorders of
large arteries such as Kawasaki disease [17].
The aim of this study was to assess delayed contrast
enhancement MRI of the coronary artery vessel wall in patients
with TA and to compare these results to those in patients with
known stable CAD.
Methods
Patients
We prospectively enrolled 9 patients (1 male, average age
46.2613.4 years) fulfilling the American College of Rheumatology
(ACR) criteria of TA. Diagnoses of all patients were made by
specialists in rheumatology. Average history of TA was 13.861.5
years. Affected large vessels, recent and past immune suppressive
therapy and further patient information are given (Table S1 and
S2). Additionally we tested the following laboratory parameters on
the day of the CMR scan: c-reactive protein (CRP), erythrocyte
sedimentation rate (ESR) and blood count. In no patients was
CAD known or documented in their history. In four patients with
TA a coronary angiogram had been performed previously.
Angiography was performed for suspected stenosis of the upper
limb arteries or to evaluate aortic regurgitation.
In the CAD group 9 patients participated (8 male, average age
65610 years); in all of them the diagnosis of significant CAD was
based on x-ray angiography with stenosis $50%. There was no
sign or suspicion of acute inflammation in any of the CAD
patients. All CAD patients had clinical indications to undergo
cardiac MRI.
Patients were not included if they were clinically unstable (e.g.
unstable angina pectoris), had any medical history of anaphylac-
toid reaction or had any contraindication for MRI examination.
The study was conducted in accordance with the ethical standards
defined by local law. In general, written informed consent from
patients was obtained before their inclusion in the study. In
addition, all participants gave a signature, that their data could be
used in anonymized form for scientific work.
MR imaging protocol
The MR imaging protocol was followed as previously described
[14]. In brief, all participants were examined in the supine position
using a commercial 3.0 T whole-body MR imaging system
(Achieva 3.0 T, Dual Transmit; Philips, Best, The Netherlands). A
32-element cardiac phased-array coil was used for signal
reception. Cardiac synchronization was performed using a vector
electrocardiogram [18]. All subjects underwent a standardized
MR examination consisting of the following steps:
For localization of the heart in the three standard planes (axial,
coronal and sagittal), a single shot SSFP sequence (multistack,
multislice survey scan, TR/TE/flip angle = 3.8 ms/1.8 ms/
20uwas used. This scan was also used for localization of the
respiratory navigator. Next, an axial mid-ventricular cine-
segmented balanced SSFP sequence with 50 cine frames was
performed to visually determine the individual rest period of the
coronaries in diastole. Timing of the coronary MRI acquisition
within the cardiac cycle (trigger delay) was then adapted to each
patient’s individual coronary artery rest period. For gating and
subsequent correction of diaphragmatic motion during free
breathing, a navigator (gating window: 5 mm) was placed at the
dome of the right hemi-diaphragm.
A bolus of 0.1 mmol/kg body weight Gd-DTPA (low/single-
dose) (MagnevistH, Bayer-Schering, Berlin, Germany) at an
injection rate of 2 ml/s, followed by a flush of 20 ml of saline
solution at the same rate, was then administered intravenously.
Magnetic resonance coronary angiography (MRCA) of the right
and/or left coronary artery system after contrast was performed
with a previously described navigator-gated free-breathing and fat-
suppressed, cardiac-triggered T2-prepared segmented k-space
gradient echo imaging sequence [15]. The acquired voxel size
was 0.76163 mm3, reconstructed to 0.760.761.5 mm3.
The subsequent LGE scans of the coronary vessel wall were
performed before and 3965 minutes after contrast administration
with a navigator-gated free-breathing and cardiac-triggered T1-
weighted inversion prepared and fat-suppressed 3D black-blood
segmented k-space gradient echo imaging sequence. In a previous
study by our group we observed that LGE of the coronary vessel
wall was already detectable 30–45 minutes after administration of
contrast agent. The best results were achieved between 30 and
60 minutes, which seems to be similar for detection of LGE in the
aorta [15]. Imaging after 30 minutes is needed due to the
necessary wash-out of contrast from the blood-pool. Scans of the
right and left coronary artery system were performed in the same
orientation as the previously acquired T2prep images, to ensure
adequate co-registration. Parameters of the sequence were: TR/
TE/flip angle = 4.7 ms/1.6 ms/20u. Spatial resolution of the
sequence was 16162 mm3 and reconstructed to 0.760.761 mm3.
The inversion time (TI) of the inversion recovery sequence used to
null blood was individually adapted in every patient. Subsequently
a noise-scan was performed to assess noise [19].
MRI image analysis
All images were interpreted by the consensus of two experienced
observers. Left ventricular enddiastolic volume (LVEDV) and left
ventricular endsystolic volume (LVESV) were estimated using the
area length method in the absence of regional wall motion
abnormalities (WMA). In the case of wall motion abnormalities
Simpson’s method was used for evaluation of LVESV and
LVEDV. Left ventricular ejection fraction (LVEF) was calculated
by subtracting LVESV from LVEDV. Late gadolinium enhance-
ment (LGE) of the myocardium was estimated visually.
For analysis of coronary arteries a 15-segment model according
to the American Heart Association segmentation was used [20].
Coronary arteries with at least 1 visible coronary segment on
T2prep scan were included in the analysis. Coronary artery
segments with stents or coronary artery bypass grafts (CABG) were
excluded because of potential artifacts.
Firstly we assessed the coronary artery segments on a segment-
by-segment basis as visible or nonvisible using the T2prep images
by consensus of two experienced readers. All coronary arteries
with LGE were assigned to the corresponding coronary arteries
seen on T2prep images (Figure 1 A, D, G) and the number of
enhanced segments was evaluated. For quantitative measurement
we used View Forum software (Philips). The same procedure was
performed for the visible parts of the ascending aorta. To
determine the signal intensity (SI) of blood a contour was
manually drawn in the ascending aorta. SI of coronary wall was
assessed in each segment twice and the average was calculated.
Noise was measured in the noise scans by drawing a contour
manually. Signal to noise (SNR= (SIwall or SIblood)/SD of noise)
ratio was estimated with SNR=SI/SD of noise. Contrast
enhancement within the coronary wall and the aortic wall was
defined as the contrast to noise ratio (CNR). CNR= (SIwall-
SIblood)/SD of noise [21].
In the TA group quantitative measurements of one patient had
to be excluded due to inaccurate noise scans.
Coronary Vessel Wall MRI in Takayasu Arteritis
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Invasive coronary angiography
In four patients with TA (patient 1, 2, 4 and 5), x-ray coronary
angiography was available. In all of these patients CAD was
excluded.
In the CAD patients, clinically indicated invasive X-ray
coronary angiography was performed within 6 months of MRI
imaging using a standard Judkins technique.
Statistics
Statistical analysis was performed using SPSS 18.0 for Windows
(SPSS Inc.). All parameters were given as mean 6 standard
deviation. Analysis with paired student t-test was used. A non-
parametric statistical test (Mann-Whitney U test) was used to
compare presence of coronary LGE and measurements of SNR
and CNR between the TA and CAD subjects. A non-parametric
statistical test (Wilcoxon-signed rank test) was used to compare
measurements of SNR and CNR within the TA and CAD subject
groups. The results were assumed to be statistically significant with
a p-value ,0.05.
Results
Two patients in the TA group had to be excluded from
quantitative analysis, one due to discomfort during MRI scan and
one because of inadequate scan quality. We also had to exclude
the results of one patient in the CAD group owing to deficient
noise scan.
The laboratory diagnostic tests in the TA group showed a
slightly elevated CRP in 5 patients; overall CRP (mg/dl; normal
range ,0.5) was 2.362.8. The blood count was normal: in detail
average white blood cells (WBC) count (K/ml, normal range ,10)
was 8.8462.9 and slightly elevated only in three patients (Table
S1).
Left ventricular function and scar imaging
All patients in the TA group showed normal LVEF without
WMA. No myocardial LGE was detected. Furthermore all
patients had normal cardiac parameters (Table 1). The numbers
Figure 1. Representative T2prep images of the right coronary artery (RCA) (A) and the left main stem (D) in a patient with TA. B and
E show the post IR scan of the same patient, revealing late gadolinium enhancement (LGE) of the coronary artery wall. C and F depict the
corresponding x-ray angiography.
doi:10.1371/journal.pone.0050655.g001
Table 1. Cardiac parameters of patients with Takayasu
arteritis (TA) or coronary artery disease (CAD).
TA (N=9) CAD (N=9)
age ± one SD (years) 46.1613.4 65610
male 1 8
left ventricular parameters
LVEF (% ± SD) 61.764.6 55.967.8
LVEDD/mm ± SD) 49.864.4 52.464.7
LVESV (ml ± SD) 52.4610.4 75.6631.9
LVEDV (ml ± SD) 136.3622.7 165.7640.4
WMA at rest (# of pts.) 0 4
LGE (# of pts.) 0 3
coronary artery segments
imaged
28 25
doi:10.1371/journal.pone.0050655.t001
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of affected vessels separated for each TA patient are given in Table
S2.
CAD patients had a normal LVEF and normal cardiac
parameters as well. In three patients myocardial LGE was present;
two of them showed WMA. Overall, four patients had WMA at
rest (Table 1).
Late gadolinium enhancement (LGE) of the coronary
artery vessel wall in TA and CAD patients
Twenty-eight of 50 visible segments (56%) in the TA group
showed LGE (Figure 1). In these 28 coronary segments with
LGE, quantitative assessment revealed a SNR of 18.466.7 (range:
10.5–26.8) and a CNR of 6.062.4 (range: 3.1–9.2).
In the CAD group LGE was observed in 25 of the visible 57
segments (44%) (Figure 2). The quantitative analysis showed a
SNR of 10.762.2 (range: 8.5–15.3) and a CNR of 7.362.5 (range:
4.9–12.1) (Table 2). Statistically there was no difference
(p = 0.474) in LGE between the two groups (Figure 3).
No increase in signal intensity of the coronary vessel wall was
observed prior contrast administration, either in patients with TA
(Figure 4) or in CAD patients (Figure 2).
Late gadolinium enhancement (LGE) of the aorta in TA
and CAD patients
In the TA group quantitative assessment of the aortic wall
demonstrated a significant increase of SNR and CNR post
contrast administration (Figure 5). Before contrast agent we
estimated a SNR of 8.866.5 (range: 0.0–19.0) and a CNR of
5.364.5 (range: 0.0–12.2); 3965 minutes after gadolinium
administration we observed a significant augmentation of SNR
(26.569.6; range: 16.5–43.9) and CNR (13.565.7; range: 7.2–
25.0). In the CAD group the estimation of SNR and CNR prior to
contrast application was 4.163.1 (range: 0.0–7.1) and 2.562.3
(range: 0.0–5.2). After contrast application we assessed a SNR of
7.763.7 (range: 0.0–11.1) and a CNR of 4.762.4 (range: 0.0–6.7)
(Table 2).
Vessel wall enhancement of the aorta differed significantly
before (p = 0.028) and after contrast application (p= 0.001)
(Figure 6).
Figure 2. Figure A shows the T2prep image of the RCA in a patient with CAD, while B represents the x-ray angiography and C the IR
scan pre and D the IR scan post gadolinium administration in the same patient. At the bottom right of Figure 1D is the enlarged cross
sectional view of the appended IR scan.
doi:10.1371/journal.pone.0050655.g002
Table 2. Quantitative MRI measures of signal-to-noise ratios
(SNR) and contrast-to-noise-ratios (CNR) of patients with TA or
CAD.
TA (N=9) CAD (N=9) p-value
LGE coronary artery wall
6.062.4 7.362.5 0.474
18.466.7 10.762.2 0.015
LGE aortic wall prior Gd
5.364.5 2.562.3 0.024
8.866.5 7.763.7 0.092
LGE aortic wall after Gd
13.565.7 4.762.4 0.001
26.569.6 7.763.7 0.001
doi:10.1371/journal.pone.0050655.t002
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A statistically significant relationship between systemic inflam-
matory parameters and local coronary LGE or aortic LGE was
not observed with this small number of patients.
Discussion
In our study we demonstrated that late gadolinium enhance-
ment (LGE) of the coronary wall occurs in patients with TA
(without clincially overt coronary artery problems), which may
indicate inflammation and/or fibrosis. We found no difference in
quantitative measurements of coronary artery vessel wall LGE
between patients with TA and patients with known CAD.
TA is a rare inflammatory disease with unknown etiology,
mostly affecting women, and marked by panarteritis of the aorta
and its major branches. In our population, 8 of nine patients with
TA were women. Affected vessels become thickened, fibrotic and
susceptible to thrombotic lesions. Due to these pathogenic
processes the vessels may develop stenotic or aneurysmal areas.
Diagnosis of TA is based on clinical presentation, physical
examination, laboratory findings and imaging modalities. Patients
present with systemic non-specific clinical symptoms, such as fever,
fatigue, weight loss and arthralgia.
So far there are no specific laboratory markers; common
inflammatory markers such as CRP or ESR may be increased but
showed no ability to distinguish between healthy patients and
those with TA [22]. However, in a recent retrospective analysis of
surgery versus endovascular intervention in TA patients it was
shown, that biological inflammation at the time of revasculariza-
tion increased the likelihood of complications [23].
Thus the diagnosis of TA still represents a challenge and
imaging modalities have a rising impact and are crucial for the
diagnosis. Increasing use of MRI for diagnosis of TA was observed
during the last decade. The combination of T2 weighted images
and contrast enhanced 3D magnetic resonance angiography
(MRA) provides high-resolutional information on edema [4,24],
wall thickening and aneurysmatic formations and so represent an
excellent alternative to conventional x-ray angiography. It was
shown that after contrast agent application marked aortic arterial
wall enhancement was observed in patients with TA [25] who
underwent MRI.
Heart failure predicts the long-term prognosis of TA and seems
to be the most common cause of death [26–28]. It is known that
coronary involvement could occur in TA and three different
pathological types of coronary artery involvement are known:
occlusion or stenosis of the coronary ostium or the proximal
segments; coronary arteriitis with diffuse or focal pattern and
finally coronary aneurysm [29]. Most frequently the proximal
segments of coronary arteries, seem to be affected, especially the
left main stem (LM) and the left anterior descending artery (LAD)
[29].
Besides TA, which presents as an inflammatory disease, it is
widely accepted that inflammation plays a key role in the initiation
and maintenance of atherosclerosis [10]. In recent studies it was
possible to show that LGE is present in coronaries in CAD patients
with stable disease [14–16] as well as in acute myocardial
infarction [30], while no coronary LGE was observed in healthy
subjects [14,15]. However, gadolinium-based contrast agents are
unspecific and the mechanism leading to contrast enhancement of
the vessel wall and the potential differentiation between fibrosis
and inflammation have not been fully investigated.
To our knowledge, this is the first study of assessment of
coronary artery wall with MRI in patients with TA. Our findings
suggest that late gadolinium enhancement (LGE) of the coronary
wall occurs in patients with TA, which may indicate inflammation
and/or fibrosis. Before contrast administration we did not find any
coronary vessel wall enhancement, either in TA or in CAD
patients.
Figure 4. Figure A shows a T2prep image of the RCA in a patient with TA, while B represents the IR scan pre- and C the IR scan post-
gadolinium administration in the same patient. The white arrow indicates the area of localized coronary artery vessel wall enhancement in C,
the dotted arrow the coronary segment without LGE of the coronary vessel wall post contrast in the same coronary artery.
doi:10.1371/journal.pone.0050655.g004
Figure 3. No significant difference of coronary CNR post
contrast was seen between the patients with TA and those
with CAD.
doi:10.1371/journal.pone.0050655.g003
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Surprisingly there was no difference in quantitative measurements
post contrast between patients with TA and patients with known
CAD. The impact of these findings is still unclear; mostly coronary
involvement in TA is not evident until the onset of typical clinical
symptoms and is considered during autopsy [29]. No myocardial
scar orWMA abnormalities at rest were found in patients with TA as
evidence for prior myocardial infarction. Hence, we cannot predict
whether coronary inflammation/fibrosis may be accountable for
myocardial ischemia or cardiac failure in TA, although there are
case reports about acute myocardial infarction in patients with the
disease. Besides this, pathological reports have shown the incidence
of myocardial inflammation [31]. Our study reported a subclinical
involvement of the coronary vessel wall in TA patients. All TA
patients were asymptomatic from a cardiac viewpoint, therefore,
evidence of coronary vessel wall enhancement might hold a potential
for a surrogate of subclinical cardiovascular disease, especially when
cardiovascular risk assessment is not supported by presence of
classical atherosclerotic risk factors. Dependent on further studies,
evaluation of coronary vessel wall enhancement might serve as a
potential therapeutic target to reduce coronary vessel wall inflam-
mation in TA patients in the future.
We observed LGE in the aortic wall in all TA patients. Our
findings are consistent with those of Desai et al. [21], who also
reported increased CNR of the aortic wall after contrast application.
All TA patients showed elevated aortic signal intensity before
contrast application, and so CNR assessment was possible even
before contrast application. The reason why we were able to
perform quantitative measures of the aortic wall before contrast
administration might be related to the larger size of the aortic wall
(thicker walls) relative to the coronary artery vessel walls in which we
were unable to measure CNR pre contrast. We found a significant
increase of CNR after gadolinium administration, which may
indicate inflammation or fibrosis of the aortic wall. The mechanisms
which induce this LGE are still unknown, because histological
confirmation is rare. Furthermore it is unclear whether LGE and
CNR assessment may serve as indicators for response to therapy. All
of our patients had a long duration of disease with long-term
immunosuppressive therapy; therefore it was not possible to
distinguish between enhancement in active and stable disease.
Recently an animal model showed the feasibility in specifically
detecting atherosclerotic lesions and their progression or regression
in MRI. Further studies are necessary, but these results are
promising for future studies [32].
Limitations
Our study is limited due to the small number of patients related
to the rareness of TA. Therefore, a correlation between
Figure 5. A shows the 3D reconstruction of a MR angiography and demonstrates a typical aneurysmal lesion of the ascending aorta
caused by prolonged TA. Figure B shows an IR scan of the aorta in the sagittal plane before contrast administration in a TA patient. C depicts the
same aorta post gadolinium application with reduced cross sectional view at the bottom. Exemplary IR image of the ascending aorta before contrast
application in a patient with stable CAD (D). E represents the same aorta post contrast administration.
doi:10.1371/journal.pone.0050655.g005
Figure 6. Both groups showed a significant increase of CNR of
the aortic wall after contrast application with p=0.028 in each
group. The rise after contrast was significant higher in the TA than in
the CAD group (p = 0.001). Interestingly there was no difference
between post contrast in CAD compared to pre contrast in TA
(p = 0.686) and no difference could be observed between the two pre
contrast CNRs (p = 0.195).
doi:10.1371/journal.pone.0050655.g006
Coronary Vessel Wall MRI in Takayasu Arteritis
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inflammatory laboratory markers and LGE of the coronary and
aortic vessel wall was not possible.
On average, TA patients were around 20 years younger than
CAD patients. In addition, most of the TA patients were women
while most of the CAD patients were men. Therefore, a direct
comparison of a gender- and age-matched group of patients with
TA and CAD was not possible and not aim of this feasibility study,
in which findings in patients with two different illnesses (TA and
CAD) were compared. Future studies should evaluate the
specificity of coronary LGE by testing if coronary vessel wall
LGE can be detected in young women without a history or signs of
an inflammatory vessel disease or stable CAD.
In addition it would be helpful to perform the same procedure
in patients in acute and stable disease to discover whether
differences exist and may be influenced by therapy.
Conclusions
We showed that LGE of the coronary vessel wall can be
detected by MRI and is common in patients with TA. In addition,
the prevalence and amount of coronary enhancement after
gadolinium (CNR) in TA seems to be similar to that in patients
with CAD, while the impact of these findings in patients with
different types of disease is unclear.
The observed coronary LGE in patients with TA or CAD seems
to be rather unspecific, and differentiation between coronary vessel
wall fibrosis and inflammation still remains unclear.
Supporting Information
Table S1 Shows the details of TA patients’ characteris-
tics and their medication history with immunosuppres-
sive medication.
(TIF)
Table S2 Affected vessels separated for each TA
patient.
(TIF)
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